Application of microbial bioinformatics to investigate corneal infections
应用微生物生物信息学研究角膜感染
基本信息
- 批准号:NE/T014148/1
- 负责人:
- 金额:$ 1.3万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2020
- 资助国家:英国
- 起止时间:2020 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
MRC : Michael Glenn: G90894FThe cornea is the thin, transparent layer at the front of eye which focuses light and protects against environmental irritants. If the cornea is damaged it can become susceptible to infection by microorganisms and then becomes inflamed, a condition known as 'keratitis'. This can result in the development of corneal ulcers, open sores which cause the cornea to become opaque and can lead to rapid loss of vision. The major risk factor for keratitis in western countries such as the UK and Canada is the misuse of contact lenses. Overnight wear or the improper cleaning of the lenses provides an environment for harmful bacteria to thrive. Keratitis is thus a severe, sight-threatening condition which requires rapid treatment in order to limit damage and preserve sight. Current treatment relies on aggressive use of antibiotics, an approach which is becoming less effective due to the alarming rise in antibiotic resistance. To combat this threat we need to develop improved diagnostic tools that can guide more targeted therapies. I believe that such tools can be developed by studying the DNA sequences of the bacteria which cause the infections. This genomic approach could augment or even replace the current assays which rely on growing the bacteria in the lab, a process that takes days to weeks to provide a result. My work to date has used a technique known as 'whole genome sequencing' (WGS) to obtain the complete DNA sequences or 'genomes' of the bacteria that have caused ~100 cases of keratitis in the UK. We now need to analyse these genomes in great detail and look for features inherent to keratitis pathogens. For example, genes which infer resistance to the major antibiotic drug classes. This will help to explain how the disease progresses and form the basis of new rapid diagnostic tests that will be able to detect similar bacteria that are present in new cases of keratitis.The aim of the proposed exchange visit to Canada is to facilitate this analysis of the genome sequences. This presents a considerable challenge because each genome comprises ~3 million letters or 'nucleotides'. Professor Brinkman's laboratory in Simon Fraser University (SFU), in Vancouver is a world leader in the development of software designed specifically to interrogate genome sequences. During my stay at her lab in the computational hub at SFU I will firstly compare all my keratitis genome sequences and others available in databases to identify common elements potentially involved in the disease. I will then apply tools designed specifically to investigate antimicrobial gene resistance profiles. Phylogenetic analysis will then be used to generate a 'family tree' that will reveal the relatedness between the different bacterial strains that cause keratitis. Detailed analysis of the proteins encoded by the keratitis bacteria will enable prioritization of targets for future development of therapeutic agents to treat the condition. The experience gained working with a team of bioinformaticians will greatly increase my computational skills and promote my future career in this expanding field.The anticipated outcome from the exchange visit is a better understanding of the genomic features of the bacteria which cause keratitis. This will guide my development of diagnostic tests back in my home laboratory in Queen's University Belfast. This will contribute to the long term goal of guiding treatment selection to facilitate a more personalized and effective approach for patients with keratitis.
角膜是位于眼睛前部的薄而透明的一层,它能聚焦光线并保护眼睛免受环境的刺激。如果角膜受损,它很容易受到微生物的感染,然后发炎,这种情况被称为“角膜炎”。这可能会导致角膜溃疡的发展,开放性溃疡会导致角膜变得不透明,并导致视力迅速丧失。在英国和加拿大等西方国家,角膜炎的主要风险因素是隐形眼镜的滥用。过夜佩戴或不正确的清洁镜片为有害细菌的滋生提供了环境。因此,角膜炎是一种严重的、威胁视力的疾病,需要迅速治疗,以限制损害和保持视力。目前的治疗依赖于大量使用抗生素,由于抗生素耐药性的惊人上升,这种方法的效果越来越差。为了对抗这种威胁,我们需要开发改进的诊断工具,以指导更有针对性的治疗。我相信这种工具可以通过研究引起感染的细菌的DNA序列来开发。这种基因组方法可以增强甚至取代目前依赖于在实验室培养细菌的检测方法,这一过程需要几天到几周的时间才能得出结果。到目前为止,我的工作已经使用了一种被称为“全基因组测序”(WGS)的技术来获得导致英国约100例角膜炎的细菌的完整DNA序列或“基因组”。我们现在需要非常详细地分析这些基因组,并寻找角膜炎病原体固有的特征。例如,推断对主要抗生素类药物耐药的基因。这将有助于解释这种疾病是如何发展的,并形成新的快速诊断测试的基础,这些测试将能够检测出角膜炎新病例中存在的类似细菌。加拿大交流访问的目的是促进基因组序列的分析。这带来了相当大的挑战,因为每个基因组包含约300万个字母或“核苷酸”。布林克曼教授在温哥华西蒙弗雷泽大学(Simon Fraser University, SFU)的实验室是开发专门用于询问基因组序列的软件的世界领先者。在她位于SFU计算中心的实验室期间,我将首先比较我所有的角膜炎基因组序列和数据库中可用的其他序列,以确定可能与该疾病有关的共同因素。然后,我将应用专门设计的工具来调查抗微生物基因抗性谱。然后,系统发育分析将用于生成“家谱”,揭示导致角膜炎的不同细菌菌株之间的相关性。对角膜炎细菌编码的蛋白质的详细分析将使未来开发治疗这种疾病的药物的目标优先化。与生物信息学家团队一起工作的经历将大大提高我的计算技能,并促进我未来在这一不断发展的领域的职业发展。交流访问的预期结果是更好地了解导致角膜炎的细菌的基因组特征。这将指导我在贝尔法斯特女王大学的家庭实验室开发诊断测试。这将有助于指导治疗选择的长期目标,以促进对角膜炎患者更个性化和有效的方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Simpson其他文献
Measuring the Social Benefits of EPA Land Cleanup and Reuse Programs
衡量 EPA 土地清理和再利用计划的社会效益
- DOI:
- 发表时间:
2006 - 期刊:
- 影响因子:0
- 作者:
Robin R. Jenkins;E. Kopits;David Simpson - 通讯作者:
David Simpson
EPIC: A Phase 3 Trial of Ponatinib Compared With Imatinib in CP-CML Patients
- DOI:
10.1016/j.clml.2015.04.076 - 发表时间:
2015-06-01 - 期刊:
- 影响因子:
- 作者:
Jeffrey H. Lipton;Charles Chuah;Agnes Guerci-Bresler;Gianantonio Rosti;David Simpson;Stephanie Lustgarten;Victor M. Rivera;Tim Clackson;Frank G. Haluska;Michele Baccarani;Jorge E. Cortes;Francois Guilhot;Andreas Hochhaus;Timothy P. Hughes;Hagop Kantarjian;Neil P. Shah;Moshe Talpaz;Michael W. Deininger - 通讯作者:
Michael W. Deininger
HIV-Associated Neuropathic Pain
- DOI:
10.2165/00023210-200519040-00005 - 发表时间:
2005-01-01 - 期刊:
- 影响因子:7.400
- 作者:
Susama Verma;Lydia Estanislao;David Simpson - 通讯作者:
David Simpson
A Phase 1 Study with the Novel B-Cell Lymphoma 2 (Bcl-2) Inhibitor Bgb-11417 As Monotherapy or in Combination with Zanubrutinib (ZANU) in Patients (Pts) with CLL/SLL: Preliminary Data
一项使用新型 B 细胞淋巴瘤 2(Bcl-2)抑制剂 Bgb-11417 作为单药治疗或与 zanubrutinib(ZANU)联合治疗慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(CLL/SLL)患者(pts)的 1 期研究:初步数据
- DOI:
10.1182/blood-2022-169662 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:23.100
- 作者:
Chan Y. Cheah;Constantine S. Tam;Masa Lasica;Emma Verner;Peter J. Browett;Mary Ann Anderson;James Hilger;Yiqian Fang;David Simpson;Stephen Opat - 通讯作者:
Stephen Opat
New products and industries from biodiversity
生物多样性带来的新产品和新产业
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:0
- 作者:
A. Beattie;W. Barthlott;K. Kate;E. Elisabetsky;R. Farrel;Chua Teck Kheng;Iain Prance;J. Rosenthal;David Simpson;R. Leakey;M. Wolfson - 通讯作者:
M. Wolfson
David Simpson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Simpson', 18)}}的其他基金
Diversity in blood flow control to the brain: moving from individualized modelling towards personalized treatment of the injured brain
大脑血流控制的多样性:从个性化建模转向受伤大脑的个性化治疗
- 批准号:
EP/K036157/1 - 财政年份:2014
- 资助金额:
$ 1.3万 - 项目类别:
Research Grant
Pan American Advanced Sciences Institute On Geophysical Research: New Tools and Techniques for Earthquake Hazard Analysis & Mitigation; Santo Domingo, Dominican Republic, July
泛美地球物理研究高级科学研究所:地震灾害分析的新工具和技术
- 批准号:
1242259 - 财政年份:2013
- 资助金额:
$ 1.3万 - 项目类别:
Standard Grant
EAPSI: Cosmological Expansion and Collapse via Loop Quantum Gravity and Superstring Theory
EAPSI:通过环量子引力和超弦理论的宇宙膨胀和坍缩
- 批准号:
1015387 - 财政年份:2010
- 资助金额:
$ 1.3万 - 项目类别:
Fellowship Award
Collaborative Research: Collection of Open Data for Broadband Seismological Observations of Aftershocks of the February 27, 2010 Chilean Earthquake
合作研究:2010 年 2 月 27 日智利地震余震宽带地震观测开放数据收集
- 批准号:
1036352 - 财政年份:2010
- 资助金额:
$ 1.3万 - 项目类别:
Standard Grant
The role of microRNAs in cell:cell communication
microRNA 在细胞间通讯中的作用
- 批准号:
BB/H005498/1 - 财政年份:2010
- 资助金额:
$ 1.3万 - 项目类别:
Research Grant
MRI-Consortium: Development of a Greenland Ice Sheet Monitoring Network
MRI 联盟:格陵兰冰盖监测网络的开发
- 批准号:
0922983 - 财政年份:2009
- 资助金额:
$ 1.3万 - 项目类别:
Standard Grant
New methods for assessing the control of blood flow in the brain
评估大脑血流控制的新方法
- 批准号:
EP/G010420/1 - 财政年份:2008
- 资助金额:
$ 1.3万 - 项目类别:
Research Grant
Out of Africa: Geophysical Monitoring and Capacity Building around the World, Boston Massachusetts Workshop, February 18-19, 2008
走出非洲:世界各地的地球物理监测和能力建设,马萨诸塞州波士顿研讨会,2008 年 2 月 18-19 日
- 批准号:
0802867 - 财政年份:2008
- 资助金额:
$ 1.3万 - 项目类别:
Standard Grant
A genetic system to study resistance to the soil-borne pathogen Verticillium dahliae in strawberry
研究草莓对土传病原体大丽黄萎病的抗性的遗传系统
- 批准号:
BB/E007074/1 - 财政年份:2007
- 资助金额:
$ 1.3万 - 项目类别:
Research Grant
MRI: Acquisition of Broadband Seismic Stations for Polar Regions
MRI:获取极地宽带地震台
- 批准号:
0723044 - 财政年份:2007
- 资助金额:
$ 1.3万 - 项目类别:
Standard Grant
相似国自然基金
碳-铁-微生物对滩涂围垦稻田土壤团聚体形成和稳定的调控机制
- 批准号:41977088
- 批准年份:2019
- 资助金额:61.0 万元
- 项目类别:面上项目
水热炭的微生物陈化(Microbial-aged Hydrochar)及其对稻田氨挥发的影响机制
- 批准号:41877090
- 批准年份:2018
- 资助金额:61.0 万元
- 项目类别:面上项目
微生物发酵过程的自组织建模与优化控制
- 批准号:60704036
- 批准年份:2007
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Identification, characterization, and application of bacterial site-specific vanadium-dependent haloperoxidase enzymes
细菌位点特异性钒依赖性卤过氧化物酶的鉴定、表征和应用
- 批准号:
10663337 - 财政年份:2022
- 资助金额:
$ 1.3万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10593999 - 财政年份:2022
- 资助金额:
$ 1.3万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10471518 - 财政年份:2022
- 资助金额:
$ 1.3万 - 项目类别:
Mechanistic studies to develop a polysaccharide degradation signature (PDS) and its application in improving host health
开发多糖降解特征(PDS)的机制研究及其在改善宿主健康中的应用
- 批准号:
10260593 - 财政年份:2020
- 资助金额:
$ 1.3万 - 项目类别:
Mechanistic studies to develop a polysaccharide degradation signature (PDS) and its application in improving host health
开发多糖降解特征(PDS)的机制研究及其在改善宿主健康中的应用
- 批准号:
10099985 - 财政年份:2020
- 资助金额:
$ 1.3万 - 项目类别:
Mechanistic studies to develop a polysaccharide degradation signature (PDS) and its application in improving host health
开发多糖降解特征(PDS)的机制研究及其在改善宿主健康中的应用
- 批准号:
10407070 - 财政年份:2020
- 资助金额:
$ 1.3万 - 项目类别:
Mechanistic studies to develop a polysaccharide degradation signature (PDS) and its application in improving host health
开发多糖降解特征(PDS)的机制研究及其在改善宿主健康中的应用
- 批准号:
10643928 - 财政年份:2020
- 资助金额:
$ 1.3万 - 项目类别:
Application of Novel Antigens and Integrated Microfluidics for Leprosy Diagnosis
新型抗原和集成微流控技术在麻风病诊断中的应用
- 批准号:
8133489 - 财政年份:2009
- 资助金额:
$ 1.3万 - 项目类别:
Application of Novel Antigens and Integrated Microfluidics for Leprosy Diagnosis
新型抗原和集成微流控技术在麻风病诊断中的应用
- 批准号:
8316325 - 财政年份:2009
- 资助金额:
$ 1.3万 - 项目类别:
Application of Novel Antigens and Integrated Microfluidics for Leprosy Diagnosis
新型抗原和集成微流控技术在麻风病诊断中的应用
- 批准号:
7940892 - 财政年份:2009
- 资助金额:
$ 1.3万 - 项目类别: